0002020737 2026-01-01 2026-06-30 0002020737 2026-08-13 0002020737 2026-06-30 0002020737 2025-12-31 0002020737 2026-04-01 2026-06-30 0002020737 2025-04-01 2025-06-30 0002020737 2025-01-01 2025-06-30 0002020737 CABR:MezzanineEquityMember 2024-12-31 0002020737 us-gaap:CommonStockMember 2024-12-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002020737 CABR:CommonStockPayableMember 2024-12-31 0002020737 CABR:SubscriptioReceivableMember 2024-12-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2024-12-31 0002020737 us-gaap:RetainedEarningsMember 2024-12-31 0002020737 2024-12-31 0002020737 CABR:MezzanineEquityMember 2025-03-31 0002020737 us-gaap:CommonStockMember 2025-03-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002020737 CABR:CommonStockPayableMember 2025-03-31 0002020737 CABR:SubscriptioReceivableMember 2025-03-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2025-03-31 0002020737 us-gaap:RetainedEarningsMember 2025-03-31 0002020737 2025-03-31 0002020737 CABR:MezzanineEquityMember 2025-12-31 0002020737 us-gaap:CommonStockMember 2025-12-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002020737 CABR:CommonStockPayableMember 2025-12-31 0002020737 CABR:SubscriptioReceivableMember 2025-12-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2025-12-31 0002020737 us-gaap:RetainedEarningsMember 2025-12-31 0002020737 CABR:MezzanineEquityMember 2026-03-31 0002020737 us-gaap:CommonStockMember 2026-03-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002020737 CABR:CommonStockPayableMember 2026-03-31 0002020737 CABR:SubscriptioReceivableMember 2026-03-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2026-03-31 0002020737 us-gaap:RetainedEarningsMember 2026-03-31 0002020737 2026-03-31 0002020737 CABR:MezzanineEquityMember 2025-01-01 2025-03-31 0002020737 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002020737 CABR:CommonStockPayableMember 2025-01-01 2025-03-31 0002020737 CABR:SubscriptioReceivableMember 2025-01-01 2025-03-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2025-01-01 2025-03-31 0002020737 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002020737 2025-01-01 2025-03-31 0002020737 CABR:MezzanineEquityMember 2025-04-01 2025-06-30 0002020737 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002020737 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002020737 CABR:CommonStockPayableMember 2025-04-01 2025-06-30 0002020737 CABR:SubscriptioReceivableMember 2025-04-01 2025-06-30 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2025-04-01 2025-06-30 0002020737 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002020737 CABR:MezzanineEquityMember 2026-01-01 2026-03-31 0002020737 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002020737 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002020737 CABR:CommonStockPayableMember 2026-01-01 2026-03-31 0002020737 CABR:SubscriptioReceivableMember 2026-01-01 2026-03-31 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2026-01-01 2026-03-31 0002020737 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002020737 2026-01-01 2026-03-31 0002020737 CABR:MezzanineEquityMember 2026-04-01 2026-06-30 0002020737 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002020737 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002020737 CABR:CommonStockPayableMember 2026-04-01 2026-06-30 0002020737 CABR:SubscriptioReceivableMember 2026-04-01 2026-06-30 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2026-04-01 2026-06-30 0002020737 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002020737 CABR:MezzanineEquityMember 2025-06-30 0002020737 us-gaap:CommonStockMember 2025-06-30 0002020737 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002020737 CABR:CommonStockPayableMember 2025-06-30 0002020737 CABR:SubscriptioReceivableMember 2025-06-30 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2025-06-30 0002020737 us-gaap:RetainedEarningsMember 2025-06-30 0002020737 2025-06-30 0002020737 CABR:MezzanineEquityMember 2026-06-30 0002020737 us-gaap:CommonStockMember 2026-06-30 0002020737 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002020737 CABR:CommonStockPayableMember 2026-06-30 0002020737 CABR:SubscriptioReceivableMember 2026-06-30 0002020737 CABR:RepurchaseReceivableFromRelatedPartyForStockRepurchaseMember 2026-06-30 0002020737 us-gaap:RetainedEarningsMember 2026-06-30 0002020737 2025-11-01 2025-11-30 0002020737 CABR:SingleReportableSegmentMember 2026-01-01 2026-06-30 0002020737 2025-01-01 2025-12-31 0002020737 us-gaap:IntellectualPropertyMember 2026-06-30 0002020737 CABR:NovoDXCorporationMember CABR:LicenseAgreementMember 2024-06-18 2024-06-18 0002020737 CABR:NovoDXCorporationMember CABR:LicenseAgreementMember 2024-06-18 0002020737 us-gaap:IntellectualPropertyMember 2025-12-31 0002020737 CABR:NovoDXCorporationMember 2024-05-14 2024-05-14 0002020737 CABR:NovoDXCorporationMember us-gaap:CommonStockMember 2024-05-14 0002020737 CABR:TermLoanMember 2026-06-30 0002020737 CABR:TermLoanMember 2025-12-31 0002020737 CABR:GreentreePromissoryNoteMember 2025-08-06 0002020737 CABR:GreentreePromissoryNoteMember 2025-08-06 2025-08-06 0002020737 CABR:GreentreePromissoryNoteMember us-gaap:CommonStockMember 2025-08-06 2025-08-06 0002020737 CABR:GreentreePromissoryNoteMember us-gaap:CommonStockMember 2025-08-06 0002020737 CABR:GreentreePromissoryNoteMember us-gaap:WarrantMember 2025-08-06 0002020737 CABR:GreentreePromissoryNoteMember 2025-01-01 2025-12-31 0002020737 CABR:GreentreePromissoryNoteMember 2025-09-12 2025-09-12 0002020737 CABR:GreentreePromissoryNoteMember 2025-10-15 2025-10-15 0002020737 CABR:GreentreePromissoryNoteMember 2026-03-23 2026-03-23 0002020737 CABR:GreentreePromissoryNoteMember 2026-03-23 0002020737 CABR:GreentreePromissoryNoteMember 2026-01-01 2026-06-30 0002020737 CABR:GreentreePromissoryNoteMember 2026-06-30 0002020737 srt:ChiefExecutiveOfficerMember CABR:DrGlynnWilsonMember 2025-06-05 0002020737 srt:ChiefExecutiveOfficerMember CABR:DrGlynnWilsonMember 2025-06-05 2025-06-05 0002020737 srt:BoardOfDirectorsChairmanMember CABR:MrBrianJohnMember 2025-07-24 0002020737 srt:BoardOfDirectorsChairmanMember CABR:MrBrianJohnMember 2025-07-24 2025-07-24 0002020737 CABR:SafetyShotIncMember 2024-01-01 2024-12-31 0002020737 CABR:SafetyShotIncMember 2025-12-31 0002020737 CABR:SafetyShotIncMember CABR:ShortTermLoanAgreementMember 2025-11-06 0002020737 CABR:SafetyShotIncMember CABR:ShortTermLoanAgreementMember 2025-11-19 0002020737 us-gaap:CommonStockMember CABR:SettlementAndReleaseAgreementMember 2026-03-10 2026-03-10 0002020737 2026-03-10 2026-03-10 0002020737 2026-03-10 0002020737 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember CABR:SettlementAgreementDBoralCapitalLLCMember 2026-05-04 2026-05-04 0002020737 CABR:SettlementAgreementDBoralCapitalLLCMember 2026-04-30 0002020737 CABR:SettlementAgreementDBoralCapitalLLCMember 2026-06-30 0002020737 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember CABR:SettlementAgreementMember 2026-05-01 2026-05-01 0002020737 CABR:SettlementAgreementMember 2026-06-30 0002020737 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-06-30 0002020737 CABR:CommonStockPayableMember 2026-01-01 2026-06-30 0002020737 us-gaap:WarrantMember 2026-01-01 2026-06-30 0002020737 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0002020737 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-06-30 0002020737 CABR:GreentreePromissoryNoteMember us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0002020737 us-gaap:CommonStockMember 2026-03-24 2026-03-24 0002020737 CABR:SettlementAgreementMember 2025-12-31 0002020737 us-gaap:CommonStockMember 2026-05-04 2026-05-04 0002020737 CABR:SettlementAgreementDBoralCapitalLLCMember 2026-05-04 0002020737 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember CABR:SettlementAgreementMember 2026-05-08 2026-05-08 0002020737 srt:ChiefFinancialOfficerMember CABR:SettlementAgreementMember 2026-05-08 0002020737 us-gaap:CommonStockMember CABR:PurchaseAgreementsMember 2026-01-01 2026-06-30 0002020737 CABR:PurchaseAgreementsMember 2026-01-01 2026-06-30 0002020737 CABR:BrianSJohnMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0002020737 CABR:BrianSJohnMember us-gaap:CommonStockMember 2026-06-30 0002020737 CABR:TylerMooreMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0002020737 CABR:TylerMooreMember us-gaap:CommonStockMember 2026-06-30 0002020737 CABR:NovoDXMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0002020737 CABR:NovoDXMember us-gaap:CommonStockMember 2026-06-30 0002020737 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0002020737 us-gaap:CommonStockMember CABR:SecuritiesPurchaseAgreementMember 2026-01-01 2026-06-30 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember 2026-03-19 0002020737 us-gaap:SubsequentEventMember 2026-07-09 0002020737 us-gaap:SubsequentEventMember 2026-07-10 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-03-19 2026-03-19 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-03-19 0002020737 CABR:FinancingArrangementMember 2026-03-19 0002020737 us-gaap:CommonStockMember CABR:SecuritiesPurchaseAgreementMember 2026-03-19 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-06-30 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-01-01 2026-06-30 0002020737 2026-04-07 0002020737 2026-04-07 2026-04-07 0002020737 us-gaap:SeriesAPreferredStockMember 2026-06-30 0002020737 CABR:SecuritiesPurchaseAgreementMember 2026-05-29 2026-05-29 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-05-29 2026-05-29 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-05-29 0002020737 CABR:SeriesAConvertiblePreferredStockMember CABR:SecuritiesPurchaseAgreementMember 2026-06-30 0002020737 CABR:FirstArrangementMember 2026-03-24 2026-03-24 0002020737 CABR:FirstArrangementMember 2026-03-24 0002020737 CABR:SecondArrangementMember 2026-03-24 2026-03-24 0002020737 CABR:ConsultingAgreementMember 2026-06-30 0002020737 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember CABR:EmploymentAgreementMember 2025-09-04 2025-09-04 0002020737 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember CABR:EmploymentAgreementMember 2026-05-08 2026-05-08 0002020737 CABR:SettlementAgreementMember 2026-04-30 2026-04-30 0002020737 CABR:SettlementAgreementMember 2026-04-30 0002020737 CABR:SettlementAgreementMember 2026-03-19 2026-03-19 0002020737 CABR:SettlementAgreementMember 2026-05-04 2026-05-04 0002020737 CABR:SettlementAgreementDBoralCapitalLLCMember 2026-05-06 0002020737 CABR:SettlementAgreementMember 2026-05-06 2026-05-06 0002020737 us-gaap:CommonStockMember CABR:ConsultingAgreementMember 2025-12-23 2025-12-23 0002020737 CABR:ConsultingAgreementMember 2025-12-23 2025-12-23 0002020737 CABR:ConsultingAgreementMember 2025-12-29 2025-12-29 0002020737 CABR:ConsultingAgreementMember 2026-01-01 2026-03-31 0002020737 2024-04-30 0002020737 CABR:FinancingArrangementMember 2025-12-31 0002020737 CABR:GreentreeFinancialGroupIncMember 2025-12-31 0002020737 CABR:GreentreeFinancialGroupIncMember 2025-08-06 0002020737 CABR:GreentreeFinancialGroupIncMember 2025-08-06 2025-08-06 0002020737 CABR:DBoralCapitalLLCMember 2025-12-31 0002020737 CABR:DBoralCapitalLLCMember 2025-11-14 0002020737 CABR:FinancingArrangementMember 2026-03-19 2026-03-19 0002020737 2026-05-29 2026-05-29 0002020737 CABR:FinancingArrangementMember 2026-06-30 0002020737 srt:MinimumMember us-gaap:WarrantMember 2026-06-30 0002020737 srt:MaximumMember us-gaap:WarrantMember 2026-06-30 0002020737 us-gaap:WarrantMember 2026-01-01 2026-06-30 0002020737 us-gaap:StockOptionMember 2025-01-01 2025-12-31 0002020737 us-gaap:StockOptionMember 2025-12-30 0002020737 us-gaap:StockOptionMember 2025-12-31 0002020737 us-gaap:StockOptionMember 2026-06-30 0002020737 us-gaap:StockOptionMember 2026-01-01 2026-06-30 0002020737 us-gaap:OptionMember 2026-06-30 0002020737 us-gaap:StockOptionMember 2026-06-30 0002020737 srt:MinimumMember us-gaap:StockOptionMember 2026-06-30 0002020737 srt:MaximumMember us-gaap:StockOptionMember 2026-06-30 0002020737 us-gaap:StockOptionMember 2026-01-01 2026-06-30 0002020737 srt:MinimumMember us-gaap:StockOptionMember 2026-01-01 2026-06-30 0002020737 srt:MaximumMember us-gaap:StockOptionMember 2026-01-01 2026-06-30 0002020737 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-12-31 0002020737 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-06-30 0002020737 us-gaap:RestrictedStockUnitsRSUMember 2026-04-01 2026-06-30 0002020737 us-gaap:RestrictedStockUnitsRSUMember 2026-06-30 0002020737 us-gaap:SubsequentEventMember 2026-07-09 2026-07-09 0002020737 us-gaap:SubsequentEventMember 2026-07-08 0002020737 us-gaap:SubsequentEventMember CABR:SecuritiesPurchaseAgreementMember 2026-07-10 2026-07-10 0002020737 CABR:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember us-gaap:SubsequentEventMember CABR:SecuritiesPurchaseAgreementMember 2026-07-10 2026-07-10 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember CABR:SecuritiesPurchaseAgreementMember 2026-07-10 2026-07-10 0002020737 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember CABR:BKInvestmentsLLCMember 2026-07-10 2026-07-10 0002020737 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember CABR:BKInvestmentsLLCMember 2026-07-10 0002020737 us-gaap:SubsequentEventMember 2026-07-16 2026-07-16 0002020737 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2026-07-13 2026-07-13 0002020737 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2026-07-13 2026-07-13 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-16 2026-07-16 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-28 2026-07-28 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-31 2026-07-31 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-08-06 2026-08-06 0002020737 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-01 2026-07-01 iso4217:USD shares iso4217:USD shares pure CABR:Segment false Q2 --12-31 0002020737

10-Q true 2026-06-30 2026 false 001-42941 CARING BRANDS, INC. NV 99-4103908 130 S Indian River Dr. Suite 202 pbm# 1232 Fort Pierce FL 34950 (561) 896-7616 Common Stock, par value $0.001 per share CABR NASDAQ Yes Yes Non-accelerated Filer true true false false 0.001 10368226

1820365

2189232

12807

76451

124779

1909623

2326818

1909623

2326818

293805

170351

90841

6493

384646

176844

58650

384646

235494

0.001

4500

4233

4232686

0.001

1000000

0.001

100000000

9091506

14761925

9092

14762

6963403

9135341

258780 83003 -800 -800 -150000

-9788184

-7140982

-2707709

2091324

1909623

2326818

1587

3056

722

1400

865

1656

26187

21331

114723

51490

414186 489114 1514886 856147

198364

75003

730627

142945

75000

150000

638737

660448

2360236

1200582

-638737

-659583

-2360236

-1198926

-1000

287028

427

-1000

-286966

-427

-638726

-660583

-2647202

-1199353

217753

2062360

78540

88508

-935019

-660583

-4798070

-1199353

-0.10

-0.05

-0.41

-0.09

-0.10

-0.05

-0.41

-0.09

8994253

13336471

11705727

13276331

8994253

13336471

11705727

13276331

13110000

13110

4541057

-862791

3691376

13110000

13110

4541057

-862791

3691376

225000

225

224775

225000

-538770

13335000

13335

4765832

-1401561

3377606

1525

5998

6000

400

1600

-1600

382000 382000 -660583 -660583

13336925

13337

4773430

382000

-1600

-2062144

3105023

14761925

14762

9135341

83003

-800

-7140982

2091324

299581

300

350067

350367

30000 30 59970 -60000

514557

6250000

6250

3068750

3075000

137500

288015

28957

1525133

9968

3789

1944867

1844607

-1844607 -1844607

-2008476

3789

3789474

8841506

8842

6601658

537560

-800

-9149458

-2002198

250000 250 278530 -278780

181801

23166

78540

174541

-150000 -150000 444

225459

-217753

217753

-638726

4233

4232686

9091506

9092

6963403

258780

-800

-150000

-9788184

-2707709

-2647202

-1199353

150000

141350

1036496

137500

607000

-642

-48328

4891

123454

6935

146207

-11438

-1013867

-451105

50000

6000

3870000

150000

3075000

645000

56000

-368867

-395105

2189232

468998

1820365

73893

1600

60000

350367 2062360 88508

<p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zvRpQbuBQHsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">Note 1 - Organization and Business Operations Caring Brands, Inc. (the “Company”) is a Nevada corporation and was incorporated on April 24, 2024. On September 24, 2024, the Company entered into a separation and exchange agreement with Safety Shot, Inc. (“Shot”) pursuant to which, Shot exchanged its right, title and interest in and to Caring Brands, Inc., a Florida corporation (“CB FL”), free and clear of all liens and encumbrances, and in exchange thereof, the Company accepted and agreed to assume all obligations of CB FL (see Note 2 – Significant Accounting Policies). The Company’s principal business is the over-the-counter and prescription-grade health and wellness products. Going Concern Consideration The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. For the six months ended June 30, 2026, the Company incurred a net loss of $2,647,202 and used $1,013,867 of cash in operating activities. As of June 30, 2026, the Company had cash and cash equivalents of $1,820,365 and an accumulated deficit of approximately $9,788,184. The Company has generated minimal revenues to date and continues to incur operating losses as it advances its business plan. On July 17, 2026, the Company received a delisting determination from the Nasdaq Stock Market LLC (see Note 13). The Company has generated minimal revenues to date. Although the Company completed its initial public offering in November 2025, generating net proceeds of approximately $3,235,692, its ability to continue as a going concern is dependent upon its ability to generate revenues and/or obtain additional financing. Management believes that existing cash resources will be sufficient to fund operations for at least the next twelve months; however, there can be no assurance that additional capital will not be required. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-2647202

-1013867

1820365

-9788184

3235692

Note 2 - Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in the consolidated financial statements. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash and equivalents for purposes of the statement of cash flows. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of $250,000, which is currently the maximum amount insured by the FDIC for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash. Inventory Inventories will be stated at the lower of cost or market. The Company will periodically review the value of items in inventory and provide write-downs or write-offs of inventory based on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold. Inventory is based upon the average cost method of accounting. Net Loss Per Share Net loss per share is computed pursuant to section ASC 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments such as options, warrants, convertible securities and preferred stock, unless the effect is to reduce a loss or increase earnings per share. As such, options, warrants, convertible securities, and preferred stock are not considered in the calculations, as the impact of the potential shares of Common Stock would be to decrease the loss per share. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Revenue Recognition The Company generates its revenue from the sale of its products directly to the end user (the “customer”). The Company recognizes revenues by applying the following steps in accordance with FASB Accounting Standards Codification 606 “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements; 1) identify the contract with a customers, 2) identify the performance obligations in the contract, 3) determine the transactions price, 4) allocate the transaction price to performance obligations in the contract, and 5) recognize revenue as the performance obligations are satisfied. The Company’s performance obligations are satisfied when goods or products are shipped on a FOB shipping point basis as title passes when shipped. Our products are generally paid in advance of shipment or standard net 30 days and we offer no specific right of return, refund or warranty related to our products except for cases of defective products of which there have been none to date. The Company does not currently have meaningful revenue in different geographic regions or channels and therefore does not disaggregate its revenue for reporting purposes. As of June 30, 2026, the Company had no contract assets, contract liabilities or deferred contract costs recorded on its condensed consolidated balance sheet. Equity Investments The Company elected to record equity investments in privately held companies using the measurement alternative at cost, less impairment, with subsequent adjustments for observable price changes resulting from orderly transactions for identical or similar investments of the same issuer. Equity investments in privately held companies accounted for using the measurement alternative are subject to periodic impairment reviews. The Company’s impairment analysis considers both qualitative and quantitative factors that may have a significant effect on the fair value of these equity securities. Intellectual Property Intellectual property, including license agreements, is recorded at cost and amortized over its estimated useful life using the straight-line method. The Company evaluates its intellectual property for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable, in accordance with ASC 360. During the year ended December 31, 2025, the Company identified impairment indicators related to its intellectual property, including ongoing litigation involving the licensor, lack of development or commercialization activities, and significant uncertainty regarding the Company’s ability to utilize the licensed technology. Based on management’s assessment, the Company determined that the carrying amount of the intellectual property was not recoverable, as the expected undiscounted future cash flows were insufficient to recover its carrying value. Accordingly, the Company recorded a full impairment charge to write down the intellectual property to its estimated fair value of zero as of December 31, 2025. No impairment charge was recorded for the three and six months ended June 30, 2026. Schedule of Estimated Useful Life of Intellectual Property <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%; text-align: left">Intellectual Property</td><td style="width: 1%"> </td> <td style="width: 16%; text-align: center">10 years</td></tr> </table> Stock Based Compensation The Company recognizes compensation costs to employees under FASB Accounting Standards Codification 718 “Compensation - Stock Compensation” (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options and warrants. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. The Company has adopted ASU No. 2018-07 “Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. Mezzanine Equity Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future. The Series A convertible preferred stock (“Series A Preferred Stock”) was accounted for as mezzanine equity in accordance with ASC 480. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Segment Reporting The Company operates under <span id="xdx_905_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SingleReportableSegmentMember_zDhEwxnG8sCe" title="Number of operating segment">one business segment. Our Chief Operating Decision Maker (CODM) is our Chief Executive Officer. The CODM considers total net income in evaluating key business results and all of our revenue comes from one business segment. Income Taxes Prior to the separation of the Company from its then parent, the Company was included as a wholly-owned subsidiary of Safety Shot, Inc., and as such, the Company followed the guidance under ASC 740-10-30-27 to account for income taxes using the separate return approach. The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company incurred losses of $2,647,202 and $1,199,353 for the six months ended June 30, 2026 and 2025, respectively. Using a 21% tax rate at the balance sheet date, the Company’s deferred tax asset as of June 30, 2026 and December 31, 2025 would be $1,809,017, and $1,499,644 respectively with a valuation allowance of $1,809,017, and $1,499,644. Related Parties The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. See Note 4 – Intangible Assets, Note 5 – Investment in NovoDX, a Related Party, Note 7 – Debt, and Note 10 Stockholders’ Equity and Mezzanine Equity. The related party mentioned in Note 4 and Note 5 is a former director at Safety Shot, a former director of Caring Brands and a current director of NovoDX Corporation. Additionally, NovoDX is a related party due to the shares of the Company’s common stock it holds as a result of the shares issued in connection with the License Agreement described in Note 4. In addition to the related party relationships described above, during the six months ended June 30, 2026, the Company repurchased shares of its common stock from certain related parties, including Brian S. John, Tyler Moore, and NovoDX, in connection with the Company’s Series A Convertible Preferred Stock private placement. See Note 10 - Stockholders’ Equity and Mezzanine Equity for further detail regarding these transactions. New Accounting Pronouncements Issued But Not Yet Adopted In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). The standard requires additional disclosures, in the notes to financial statements, of specified information about certain costs and expenses included in the captions presented on the face of the income statement. The new guidance is effective for the Company’s annual reporting period beginning January 1, 2027, and interim reporting periods beginning January 1, 2028. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company expects ASU 2024-03 to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition. In May 2025, the FASB issued ASU No. 2025-04, Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606), which is intended to reduce diversity in practice and improve existing guidance, primarily by revising the definition of a “performance condition” and eliminating forfeiture policy election for service conditions associated with share-based consideration payable to a customer. In addition, ASU No. 2025-04 clarifies that the guidance in ASC 606 on the variable consideration constraints does not apply to share-based consideration payable to a customer regardless of whether an award’s grant date has occurred (as determined under ASC 718). ASU No. 2025-04 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. We plan to adopt ASU No. 2025-04 in the first quarter of fiscal year 2028. We are currently evaluating the impact of this ASU on our financial statements and disclosures. From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective will not have a material effect on its condensed consolidated financial position or results of operations upon adoption. Recently adopted accounting pronouncements In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The new requirements apply to all entities subject to income taxes and will be effective for the Company’s annual periods beginning January 1, 2026. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company expects ASU 2023-09 to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition.

Basis of Presentation and Principles of Consolidation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements have been prepared on the same basis as its annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026, or for any other interim period or for any other future year. All intercompany balances and transactions have been eliminated in the consolidated financial statements.

Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash and equivalents for purposes of the statement of cash flows. From time to time, the Company may maintain bank balances in interest bearing accounts in excess of $250,000, which is currently the maximum amount insured by the FDIC for interest bearing accounts (there is currently no insurance limit for deposits in noninterest bearing accounts). The Company has not experienced any losses with respect to cash. Management believes our Company is not exposed to any significant credit risk with respect to its cash.

250000

Inventory Inventories will be stated at the lower of cost or market. The Company will periodically review the value of items in inventory and provide write-downs or write-offs of inventory based on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold. Inventory is based upon the average cost method of accounting.

Net Loss Per Share Net loss per share is computed pursuant to section ASC 260-10-45 of the FASB Accounting Standards Codification. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments such as options, warrants, convertible securities and preferred stock, unless the effect is to reduce a loss or increase earnings per share. As such, options, warrants, convertible securities, and preferred stock are not considered in the calculations, as the impact of the potential shares of Common Stock would be to decrease the loss per share.

Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Revenue Recognition The Company generates its revenue from the sale of its products directly to the end user (the “customer”). The Company recognizes revenues by applying the following steps in accordance with FASB Accounting Standards Codification 606 “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements; 1) identify the contract with a customers, 2) identify the performance obligations in the contract, 3) determine the transactions price, 4) allocate the transaction price to performance obligations in the contract, and 5) recognize revenue as the performance obligations are satisfied. The Company’s performance obligations are satisfied when goods or products are shipped on a FOB shipping point basis as title passes when shipped. Our products are generally paid in advance of shipment or standard net 30 days and we offer no specific right of return, refund or warranty related to our products except for cases of defective products of which there have been none to date. The Company does not currently have meaningful revenue in different geographic regions or channels and therefore does not disaggregate its revenue for reporting purposes. As of June 30, 2026, the Company had no contract assets, contract liabilities or deferred contract costs recorded on its condensed consolidated balance sheet.

Equity Investments The Company elected to record equity investments in privately held companies using the measurement alternative at cost, less impairment, with subsequent adjustments for observable price changes resulting from orderly transactions for identical or similar investments of the same issuer. Equity investments in privately held companies accounted for using the measurement alternative are subject to periodic impairment reviews. The Company’s impairment analysis considers both qualitative and quantitative factors that may have a significant effect on the fair value of these equity securities.

Intellectual Property Intellectual property, including license agreements, is recorded at cost and amortized over its estimated useful life using the straight-line method. The Company evaluates its intellectual property for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable, in accordance with ASC 360. During the year ended December 31, 2025, the Company identified impairment indicators related to its intellectual property, including ongoing litigation involving the licensor, lack of development or commercialization activities, and significant uncertainty regarding the Company’s ability to utilize the licensed technology. Based on management’s assessment, the Company determined that the carrying amount of the intellectual property was not recoverable, as the expected undiscounted future cash flows were insufficient to recover its carrying value. Accordingly, the Company recorded a full impairment charge to write down the intellectual property to its estimated fair value of zero as of December 31, 2025. No impairment charge was recorded for the three and six months ended June 30, 2026. Schedule of Estimated Useful Life of Intellectual Property <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%; text-align: left">Intellectual Property</td><td style="width: 1%"> </td> <td style="width: 16%; text-align: center">10 years</td></tr> </table>

Schedule of Estimated Useful Life of Intellectual Property <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%; text-align: left">Intellectual Property</td><td style="width: 1%"> </td> <td style="width: 16%; text-align: center">10 years</td></tr> </table>

P10Y

Stock Based Compensation The Company recognizes compensation costs to employees under FASB Accounting Standards Codification 718 “Compensation - Stock Compensation” (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options and warrants. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. The Company has adopted ASU No. 2018-07 “Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to non-employees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned.

Mezzanine Equity Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future. The Series A convertible preferred stock (“Series A Preferred Stock”) was accounted for as mezzanine equity in accordance with ASC 480. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period.

Segment Reporting The Company operates under <span id="xdx_905_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SingleReportableSegmentMember_zDhEwxnG8sCe" title="Number of operating segment">one business segment. Our Chief Operating Decision Maker (CODM) is our Chief Executive Officer. The CODM considers total net income in evaluating key business results and all of our revenue comes from one business segment.

Income Taxes Prior to the separation of the Company from its then parent, the Company was included as a wholly-owned subsidiary of Safety Shot, Inc., and as such, the Company followed the guidance under ASC 740-10-30-27 to account for income taxes using the separate return approach. The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company incurred losses of $2,647,202 and $1,199,353 for the six months ended June 30, 2026 and 2025, respectively. Using a 21% tax rate at the balance sheet date, the Company’s deferred tax asset as of June 30, 2026 and December 31, 2025 would be $1,809,017, and $1,499,644 respectively with a valuation allowance of $1,809,017, and $1,499,644.

-2647202

-1199353

0.21

1809017

1499644

1809017

1499644

Related Parties The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. See Note 4 – Intangible Assets, Note 5 – Investment in NovoDX, a Related Party, Note 7 – Debt, and Note 10 Stockholders’ Equity and Mezzanine Equity. The related party mentioned in Note 4 and Note 5 is a former director at Safety Shot, a former director of Caring Brands and a current director of NovoDX Corporation. Additionally, NovoDX is a related party due to the shares of the Company’s common stock it holds as a result of the shares issued in connection with the License Agreement described in Note 4. In addition to the related party relationships described above, during the six months ended June 30, 2026, the Company repurchased shares of its common stock from certain related parties, including Brian S. John, Tyler Moore, and NovoDX, in connection with the Company’s Series A Convertible Preferred Stock private placement. See Note 10 - Stockholders’ Equity and Mezzanine Equity for further detail regarding these transactions. New Accounting Pronouncements Issued But Not Yet Adopted In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). The standard requires additional disclosures, in the notes to financial statements, of specified information about certain costs and expenses included in the captions presented on the face of the income statement. The new guidance is effective for the Company’s annual reporting period beginning January 1, 2027, and interim reporting periods beginning January 1, 2028. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company expects ASU 2024-03 to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition. In May 2025, the FASB issued ASU No. 2025-04, Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606), which is intended to reduce diversity in practice and improve existing guidance, primarily by revising the definition of a “performance condition” and eliminating forfeiture policy election for service conditions associated with share-based consideration payable to a customer. In addition, ASU No. 2025-04 clarifies that the guidance in ASC 606 on the variable consideration constraints does not apply to share-based consideration payable to a customer regardless of whether an award’s grant date has occurred (as determined under ASC 718). ASU No. 2025-04 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. We plan to adopt ASU No. 2025-04 in the first quarter of fiscal year 2028. We are currently evaluating the impact of this ASU on our financial statements and disclosures. From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective will not have a material effect on its condensed consolidated financial position or results of operations upon adoption.

Recently adopted accounting pronouncements In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The new requirements apply to all entities subject to income taxes and will be effective for the Company’s annual periods beginning January 1, 2026. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company expects ASU 2023-09 to only impact its disclosures with no impacts to the Company’s results of operations, cash flows, and financial condition.

Note 3 - Cash and Cash Equivalents As of June 30, 2026 and December 31, 2025, the Company had a cash balance of $1,820,365 and $2,189,232 respectively.

1820365

2189232

Note 4 - Intangible Assets On June 18, 2024, the Company entered into a License Agreement with NovoDX Corporation, a related party, to license the NovoDX’s GoldNTM Ebola Rapid Diagnostic Test to market and sell the Licensed Product within the commercial field, which was Amended and Restated on July 22, 2024. In consideration for the License, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NovoDXCorporationMember_zqYvuxJvHYrd" title="Restricted shares issued">3,000,000 shares of its restricted common stock to NovoDX. The shares were issued at $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240618__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NovoDXCorporationMember_za1vP033wg76" title="Restricted shares issued, price per share">1.00 per share, the same price as the private placement offering and are being amortized over a <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240618__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NovoDXCorporationMember_zEoIHZezCQCb" title="Restricted shares issued, amortized period">10-year period. During the year ended December 31, 2025, the Company identified impairment indicators and recorded a full impairment charge to write down the carrying amount of the licensed intellectual property to zero. As of June 30, 2026 the Company had no remaining intangible asset balance. As of December 31, 2025 the Company had the following intangible asset balances: Schedule of Intangible Asset Balances <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Estimated useful life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross carrying amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated amortization</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Impairment Loss</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net carrying amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 32%; text-align: left; padding-bottom: 1pt">Intellectual property - license</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 10%; text-align: center; padding-bottom: 1pt"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zmkV3MhIYjR6" title="Estimated useful life">10 years</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zF5GsA4Pm3F5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Gross carrying amount">3,000,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zRhezwspbjbc" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Accumulated amortization">(450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iNI_di_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zbvBYa1lvS9f" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Impairment Loss">(2,550,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zA7o6eihCGj3" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Net carrying amount">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangibles</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231_zNEtgREmlXK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Gross carrying amount">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231_zvKAkp5MID17" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Accumulated amortization">(450,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iNI_di_c20251231_zgS8X3MvfyD3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Impairment Loss">(2,550,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231_zoTMPE6zpvhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Net carrying amount">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Amortization expense was $0 and $150,000 for the six months ended June 30, 2026 and 2025, respectively.

3000000

1.00

P10Y

As of December 31, 2025 the Company had the following intangible asset balances: Schedule of Intangible Asset Balances <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Estimated useful life</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross carrying amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated amortization</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Impairment Loss</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net carrying amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 32%; text-align: left; padding-bottom: 1pt">Intellectual property - license</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 10%; text-align: center; padding-bottom: 1pt"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zmkV3MhIYjR6" title="Estimated useful life">10 years</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zF5GsA4Pm3F5" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Gross carrying amount">3,000,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zRhezwspbjbc" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Accumulated amortization">(450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iNI_di_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zbvBYa1lvS9f" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Impairment Loss">(2,550,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zA7o6eihCGj3" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Intangible asset, Net carrying amount">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangibles</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20251231_zNEtgREmlXK6" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Gross carrying amount">3,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20251231_zvKAkp5MID17" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Accumulated amortization">(450,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iNI_di_c20251231_zgS8X3MvfyD3" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Impairment Loss">(2,550,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20251231_zoTMPE6zpvhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible asset, Net carrying amount">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

P10Y

3000000

-450000

2550000

3000000

-450000

2550000

150000

Note 5 - Investment in NovoDX, a Related Party On May 14, 2024, the Company purchased <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240514__20240514__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NovoDXCorporationMember_z3Wbt2G2izHg" title="Number of restricted common stock purchased">25,134 shares of NovoDX Corporation’s restricted common stock for $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240514__20240514__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NovoDXCorporationMember_zGnYCJgQ9fL2" title="Value of restricted common stock purchased">500,000. NovoDX is a diagnostic company, focusing on health products related to rapid diagnostic screenings and their companion therapeutics. NovoDX is researching and developing rapid diagnostic devices for Over the Counter and Point of Care with the focus on manufacturing, marketing and selling, directly and indirectly, those devices for at home diagnostic screening use. The investment in NovoDX Corporation’s restricted common stock (<span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240514__20240514__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NovoDXCorporationMember_zL1UT3NEGfz1" title="Number of restricted common stock purchased">25,134 shares purchased for $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240514__20240514__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NovoDXCorporationMember_zYp94HCNuU89" title="Value of restricted common stock purchased">500,000), representing less than 1% of the outstanding shares of NovoDX, is recorded at cost and the carrying value is adjusted to fair market value for each reporting period. We have chosen the fair value option to account for investment in NovoDX Corporation in accordance with ASC 321. The Company had an independent valuation completed as of October 4, 2024. The valuation focused on the market approach. The valuation concluded that the recent equity transactions at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240514__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NovoDXCorporationMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJgt0eJy2ygl" title="Restricted shares, price per share">19.89 per share were the best indicator of fair value (total value of $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240514__20240514__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NovoDXCorporationMember_zqI55ythBsPa" title="Value of restricted common stock purchased">500,000). During the year ended December 31, 2025, the Company identified impairment indicators related to the investment, including ongoing litigation, uncertainty surrounding the underlying technology, and lack of operational and commercialization activities. Based on management’s qualitative assessment under ASC 321, the Company determined that the fair value of the investment was less than its carrying amount and recorded a full loss on investment of $500,000, writing down the investment to zero as of December 31, 2025.

25134

500000

25134

500000

19.89

500000

<p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z3PflUM7S9Z8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Note 6 - Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities as of June 30, 2026 and December 31, 2025 consisted of the following: Schedule of Accrued Expenses and Other Current Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630_zxVGNglCScla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20251231_zHDu0jhqMFE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_maAPAALzhVK_zjYLbpIKbDm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued payroll and payroll taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,749</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InterestPayableCurrent_iI_maAPAALzhVK_zTS6kKtnfGt1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,744</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAALzhVK_zY8TiVsVGNs7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accrued dividend</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">88,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALzhVK_zobpgguYP73e" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">90,841</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,493</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Accrued expenses and other current liabilities as of June 30, 2026 and December 31, 2025 consisted of the following: Schedule of Accrued Expenses and Other Current Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260630_zxVGNglCScla" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20251231_zHDu0jhqMFE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_maAPAALzhVK_zjYLbpIKbDm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued payroll and payroll taxes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,749</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InterestPayableCurrent_iI_maAPAALzhVK_zTS6kKtnfGt1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,744</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAALzhVK_zY8TiVsVGNs7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accrued dividend</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">88,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALzhVK_zobpgguYP73e" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">90,841</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,493</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2333

1749

4744

88508

90841

6493

Note 7 - Debt The Company’s outstanding debt as of June 30, 2026 and December 31, 2025, consisted of the following: Schedule of Debt <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260630_zmUxlEZSMRMh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20251231_zaWO38QzNfy7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--DebtInstrumentCarryingAmount_iI_hus-gaap--DebtInstrumentAxis__custom--TermLoanMember_z8qnuhLf5qRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Term loan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DebtInstrumentCarryingAmount_iI_maLTDzqvB_zRcFiCB1i851" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredFinanceCostsNet_iNI_di_msLTDzqvB_z0frMhO9YVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: deferred financing fee</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(141,350</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iTI_mtLTDzqvB_z2Mwz0GxpiWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total debt, net of issuance costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">58,650</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtCurrent_iNI_di_zYPO9DAS5SKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtNoncurrent_iI_zbG6SNhBsCue" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion of debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Term Loan On August 6, 2025, the Company entered into a convertible promissory note for the amount of $200,000 with Greentree Financial Group, Inc (“Greentree Promissory Note”). The Greentree Promissory Note has an annual interest rate of 10% and the Greentree Promissory Note can be drawn in up to four tranches with the maturity date being five years from the date the respective tranche was drawn. The term of the agreement allows Greentree Financial Group, Inc. to convert all outstanding note balances, plus any outstanding interest charges and late fees, into our shares of Common Stock at a conversion price of $2.00 per share, or the latest sale price of Common Stock, whichever is less. The loan includes a 10% original issue discount, a one-time legal fee of $10,000, and a one-time grant of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250806__20250806__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zNen5PuwIH8l" title="Shares of common stock grant">25,000 shares of common stock. The common stock was issued to Greentree Financial Group, Inc. as of the date of the contract, with a fair value of $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250806__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zkqZAUQQDik2" title="Fair value per share">1.75 per share and was recorded as a deferred financing fee. We also issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zVgQHMUzjNJ4" title="Warrants to purchase shares">200,000 warrants to purchase shares of Common Stock with an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zrLnnoSnJH84" title="Exercise price per share">4.00 per share. The warrants issued under the Greentree Promissory Note expire on <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250806__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zE8eBH3EXntg" title="Maturity date">August 6, 2030. As of December 31, 2025, we have drawn $200,000 on the Greentree Promissory Note to pay for working capital needs of the business. The Company drew two $60,000 tranches and one $80,000 on the Greentree Promissory Note on August 13, 2025, September 12, 2025 and October 15, 2025, respectively. The maturity dates for these tranches are August 12, 2030, September 11, 2030, and October 14, 2030, respectively. Included in the issuance of this debt were discounts related to stock issued with a fair market value of $43,750 and an original issue discount of $30,000. The warrants had a fair value of $155,154, and $74,267 was recorded as a debt discount and is being amortized to interest expense over the term of the note. On March 23, 2026, the holder elected to convert the entire outstanding balance of the note into equity. Pursuant to the conversion notice, the Company issued <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20260323__20260323__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zuOuqIvyOxIj" title="Common stock issued shares">299,581 shares of common stock at a conversion price of $2.00 per share, resulting in the full settlement of the note with no remaining principal balance outstanding. In connection with the conversion, the Company recognized $148,867 of guaranteed interest on the note and $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_z1SnvpttBGe9" title="Unamortized debt discount as interest expense">141,350 of unamortized debt discount as interest expense, both credited to additional paid-in capital upon conversion. Related Party Notes Payable On June 5, 2025, we entered into a short-term loan agreement with our CEO, Dr. Glynn Wilson, to provide short-term working capital funding to the business. The loan is for an aggregate of $<span id="xdx_90A_eus-gaap--ShortTermBorrowings_iI_c20250605__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrGlynnWilsonMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zLhw1PtV4XN9" title="Short term loan">50,000, due on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20250605__20250605__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrGlynnWilsonMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zuVZUMmNTaA9" title="Short term loan due date">November 5, 2025 and carries an <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20250605__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DrGlynnWilsonMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zRHxzBDAuqN4" title="Interest rate">8% interest rate. The loan’s outstanding balance was paid in full as of June 30, 2026. On July 24, 2025, we entered into a short-term loan agreement with our Chairman of the Board, Mr. Brian John, to provide short-term working capital funding to the business. The loan is for an aggregate of $<span id="xdx_909_eus-gaap--ShortTermBorrowings_iI_c20250724__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrBrianJohnMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zwas4rMvhbPf" title="Short term loan">25,000, due on <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20250724__20250724__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrBrianJohnMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zCfavLivuKH2" title="Short term loan due date">December 24, 2025 and carries an <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20250724__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrBrianJohnMember__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zjJs2jypnOEb" title="Interest rate">8% interest rate. The loan’s outstanding balance was paid in full as of June 30, 2026. Loan with Safety Shot, a Related Party During 2024, Safety Shot, a related party and significant shareholder of the Company, paid certain operating expenses on behalf of the Company totaling $78,980. These payments were initially recorded as a payable to the related party. During the year ended December 31, 2025, Safety Shot waived its right to reimbursement of these amounts. As a result, the Company recognized settlement of related party obligations of $78,980 as additional paid in capital for the year ended December 31, 2025. As of June 30, 2026, no amounts remain outstanding related to these transactions. Related Party Short-Term Loan On November 6, 2025, the Company entered a Short-Term Loan agreement with Caro Partners (the “Lender”). The Lender advanced funds to the Company in the principal amount of Forty-Five Thousand Dollars ($<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20251106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SafetyShotIncMember__us-gaap--TypeOfArrangementAxis__custom--ShortTermLoanAgreementMember_zR8qrtPbucQ9" title="Principal amount">45,000) to assist the Company on a short-term basis to assist the Company with short-term working capital needs related to expenses associated with the Company’s NASDAQ uplisting process. The full principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20251119__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SafetyShotIncMember__us-gaap--TypeOfArrangementAxis__custom--ShortTermLoanAgreementMember_zwbtG5fHT9Cg" title="Principal amount">45,000 was repaid to the Lender on November 19, 2025.

The Company’s outstanding debt as of June 30, 2026 and December 31, 2025, consisted of the following: Schedule of Debt <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260630_zmUxlEZSMRMh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20251231_zaWO38QzNfy7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--DebtInstrumentCarryingAmount_iI_hus-gaap--DebtInstrumentAxis__custom--TermLoanMember_z8qnuhLf5qRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Term loan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DebtInstrumentCarryingAmount_iI_maLTDzqvB_zRcFiCB1i851" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredFinanceCostsNet_iNI_di_msLTDzqvB_z0frMhO9YVR8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: deferred financing fee</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(141,350</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iTI_mtLTDzqvB_z2Mwz0GxpiWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total debt, net of issuance costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">58,650</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtCurrent_iNI_di_zYPO9DAS5SKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtNoncurrent_iI_zbG6SNhBsCue" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion of debt</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

200000

141350

58650

200000

0.10

2.00

0.10

10000

25000

1.75

200000

4.00

2030-08-06

200000

60000

80000

43750

30000

155154

74267

299581

2.00

148867

141350

50000

2025-11-05

0.08

25000

2025-12-24

0.08

78980

45000

Note 8 - Commitments and Contingencies Except as disclosed below, the Company is not currently a party to any material legal proceedings, investigation or claims. As the Company may, from time to time, be involved in legal matters arising in the ordinary course of its business, there can be no assurance that such matters will not arise in the future or that any such matters in which the Company is involved, or which may arise in the ordinary course of the Company’s business, will not at some point proceed to litigation or that such litigation will not have a material adverse effect on the business, financial condition or results of operations of the Company. Legal contingencies On March 10, 2026, the Company entered into a Settlement and Release Agreement (“Settlement Agreement”) with NovoDX Corporation to resolve certain disputes between the parties, concerning (i)<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260310__20260310__us-gaap--TypeOfArrangementAxis__custom--SettlementAndReleaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z86PGrHoySZ" title="Shares issued"> 3,500,000 shares of Company’s common stock that NovoDX owns (the “CABR Shares”) and claims it has the right to sell without restriction; and (ii) assertions of fraud and misrepresentation by NovoDX with respect to the Research Collaboration and Exclusive License Agreement made and effective as of June 30 2024, between the parties (the “License Agreement”), which assertions NovoDX claims are false and baseless (the “Dispute”). Pursuant to the Settlement Agreement, the parties have agreed to settle the claims and matters related to the Dispute and agreed to mutual releases. Concurrent to the Settlement Agreement, the parties also entered into a stock purchase agreement effective March 19, 2026, pursuant to which stock purchase agreement, NovoDX agreed to sell to the Company and the Company agreed to purchase from NovoDX its holding of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260310__20260310__us-gaap--TypeOfArrangementAxis__custom--SettlementAndReleaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvaGtBnytHW9" title="Shares purchased">3,500,000 shares of the Company’s common stock for an aggregate purchase price of $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260310__20260310__us-gaap--TypeOfArrangementAxis__custom--SettlementAndReleaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPe1KAP20W1l" title="Shares purchased, value">1,075,000 in cash. The purchase price of $1,075,000 was paid in cash on March 20, 2026, and the 3,500,000 shares were returned to the Company and cancelled on March 27, 2026. On April 30, 2026, the Company entered into a settlement agreement with D. Boral Capital LLC to resolve a dispute arising from the Company’s November 2025 underwritten public offering. Under the terms of the agreement, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesOther_c20260504__20260504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementDBoralCapitalLLCMember_zHV9AIWo85F1" title="Number of shares issued">100,000 shares of its common stock on May 4, 2026 and paid $100,000 in cash on May 6, 2026 in full and final settlement of all amounts claimed. The settlement resulted in the extinguishment of $92,780 of common stock payable during the three months ended June 30, 2026. On May 1, 2026, the Company entered into a Settlement Agreement and General and Mutual Release with its former Chief Financial Officer, Tyler Moore, to resolve disputes relating to his prior employment and equity compensation. Under the terms of the agreement, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zutIAZGaGndh" title="Number of shares issued">150,000 shares of its common stock to Mr. Moore on May 8, 2026 from the Company’s Form S-8 registration statement covering the 2024 Equity Incentive Plan. The settlement shares were issued in full satisfaction of any compensation or other amounts that may have been owed to Mr. Moore, and the agreement includes mutual releases of claims between the parties. The settlement resulted in the extinguishment of $186,000 of common stock payable during the three months ended June 30, 2026.

3500000

1075000

1075000 2026-03-20

3500000

2026-03-27

100000

92780

150000

186000

Note 9 - Net Loss Per Share The Company computes basic net income per share using the weighted-average number of shares of common stock outstanding. Diluted net income per share amounts are calculated using the treasury stock method for equity-based compensation awards. Diluted net income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, using the treasury stock method or if-converted method, as applicable. As of June 30, 2026, the Company had the following potentially dilutive securities outstanding: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Series A preferred stock: <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesAPreferredStockMember_zQn0DvOSTs8f" title="Dilutive securities outstanding">10,803,358 shares (See Note 10)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Common stock payable: <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockPayableMember_zsriZVJ7YK0l" title="Dilutive securities outstanding">300,000 shares (See Note 10)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Warrants: <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZMpZyygYC15" title="Dilutive securities outstanding">12,866,317 shares (See Note 10)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Stock options: <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z7HLDcMhNmVa" title="Dilutive securities outstanding">175,000 shares (See Note 10)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Restricted stock units(“RSUs”): <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zF3ST2XZwr9l" title="Dilutive securities outstanding">522,592 shares</td></tr> </table> Potentially dilutive securities include convertible debt, common stock payable, warrants, stock options, and restricted stock units. For the three and six months ended June 30, 2026 and 2025, these instruments were excluded from the computation of diluted net income (loss) per share as their inclusion would have been anti-dilutive. The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations: Schedule of Basic and Diluted Net Loss Per Share Attributable to Shareholders <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260101__20260630_zVY8FKcbdpd5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20250101__20250630_zYeS9SNtquJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">NUMERATOR:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_maNILATzIFJ_z9wU6oR1zddk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(2,647,202</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,199,353</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--NetIncomeLossAvailableToAccretionToRedeemablePreferredEquity_msNILATzIFJ_zlXtGZYeDju9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Accretion to redeemable preferred equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,062,360</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NetIncomeLossAvailableToDividendsOnSeriesPreferredStock_msNILATzIFJ_z9XX0HPiSPU6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">88,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzIFJ_zuFpFKYDV7Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net loss attributable to common stockholders</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(4,798,070</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,199,353</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--NetIncomeLossAvailableToAddBackDividendsOnSeriesPreferredStock_zB3hLPwETVI" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Add back dividends on Series A preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zSygEW9jChA" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,798,070</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,199,353</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">DENOMINATOR:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Weighted average number of common shares outstanding – Basic and Diluted *</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,705,727</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,276,331</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">LOSSES PER SHARE:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zA3EqTfRR2h9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pid_z8z0MVwr1sl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">NUMERATOR:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260401__20260630_zkWdRCzOqFl2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20250401__20250630_zbWiK9qOOMN2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">NUMERATOR:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_maNILATzIFJ_znI049bMZBd2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(638,726</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(660,583</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--NetIncomeLossAvailableToAccretionToRedeemablePreferredEquity_msNILATzIFJ_z0JdtTV2PaR9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Accretion to redeemable preferred equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,753</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NetIncomeLossAvailableToDividendsOnSeriesPreferredStock_msNILATzIFJ_zVeNXt0aOCrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,540</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzIFJ_zFZ5BisbQgVh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Net loss attributable to common stockholders</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(935,019</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(660,583</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--NetIncomeLossAvailableToAddBackDividendsOnSeriesPreferredStock_z0fs4sQ6HCb4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Add back dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zHh1hbPYpYp4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(935,019</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(660,583</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">DENOMINATOR:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zf4Szmuk7aY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Weighted average number of common shares outstanding - Basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,994,253</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,336,471</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">LOSSES PER SHARE:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zC1aNxWSaJvl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pid_zX1yHb6j0F61" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F04_ztHQPdpGKuRj" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right">*</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Due to the anti-dilutive effect, the computation of basic and diluted EPS did not include the shares underlying the exercise of warrants, options, RSUs and Series A preferred stock as the Company had a net loss for the three and six months ended June 30, 2026 and 2025.</td></tr> </table>

10803358

300000

12866317

175000

522592

The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations: Schedule of Basic and Diluted Net Loss Per Share Attributable to Shareholders <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260101__20260630_zVY8FKcbdpd5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20250101__20250630_zYeS9SNtquJh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">NUMERATOR:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_maNILATzIFJ_z9wU6oR1zddk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(2,647,202</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,199,353</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--NetIncomeLossAvailableToAccretionToRedeemablePreferredEquity_msNILATzIFJ_zlXtGZYeDju9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Accretion to redeemable preferred equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,062,360</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NetIncomeLossAvailableToDividendsOnSeriesPreferredStock_msNILATzIFJ_z9XX0HPiSPU6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">88,508</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzIFJ_zuFpFKYDV7Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net loss attributable to common stockholders</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(4,798,070</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,199,353</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--NetIncomeLossAvailableToAddBackDividendsOnSeriesPreferredStock_zB3hLPwETVI" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Add back dividends on Series A preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zSygEW9jChA" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,798,070</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,199,353</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">DENOMINATOR:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Weighted average number of common shares outstanding – Basic and Diluted *</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,705,727</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,276,331</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">LOSSES PER SHARE:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zA3EqTfRR2h9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pid_z8z0MVwr1sl4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.41</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.09</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">NUMERATOR:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260401__20260630_zkWdRCzOqFl2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20250401__20250630_zbWiK9qOOMN2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">NUMERATOR:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_maNILATzIFJ_znI049bMZBd2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(638,726</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(660,583</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_ecustom--NetIncomeLossAvailableToAccretionToRedeemablePreferredEquity_msNILATzIFJ_z0JdtTV2PaR9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Accretion to redeemable preferred equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,753</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NetIncomeLossAvailableToDividendsOnSeriesPreferredStock_msNILATzIFJ_zVeNXt0aOCrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">78,540</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzIFJ_zFZ5BisbQgVh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Net loss attributable to common stockholders</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(935,019</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(660,583</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--NetIncomeLossAvailableToAddBackDividendsOnSeriesPreferredStock_z0fs4sQ6HCb4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Add back dividends on Series A preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zHh1hbPYpYp4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(935,019</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(660,583</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">DENOMINATOR:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zf4Szmuk7aY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Weighted average number of common shares outstanding - Basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,994,253</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,336,471</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">LOSSES PER SHARE:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_pid_zC1aNxWSaJvl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pid_zX1yHb6j0F61" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net loss per common share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F04_ztHQPdpGKuRj" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right">*</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Due to the anti-dilutive effect, the computation of basic and diluted EPS did not include the shares underlying the exercise of warrants, options, RSUs and Series A preferred stock as the Company had a net loss for the three and six months ended June 30, 2026 and 2025.</td></tr> </table>

-2647202

-1199353

2062360 88508

-4798070

-1199353

-4798070

-1199353

11705727

13276331

-0.41

-0.09

-0.41

-0.09

-638726

-660583

217753 78540

-935019

-660583

-935019

-660583

8994253

13336471

-0.10

-0.05

-0.10

-0.05

Note 10 – Stockholders’ Equity and Mezzanine Equity Common Stock – The Company has 100,000,000 shares of Common Stock, par value $0.001 authorized and has 9,091,506 and 14,761,925 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. The cumulative changes to equity since inception include: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the six months ended June 30, 2026, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember_zQvJ9xIVeOS2" title="Shares of common stock">299,581 shares of common stock to Greentree Financial Group, Inc. upon full conversion of the convertible promissory note originally dated August 6, 2025, $2.00 per share for principal of $200,000 and fees of $1,500. Guaranteed interest of $148,867 was converted at the alternate conversion price of $0.7487 calculated as 90% of the lowest VWAP of the Common Stock during the five consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice. The conversion prices were within the contractual terms of the note agreement. The conversion resulted in the full extinguishment of the outstanding obligation, including principal of $200,000 and guaranteed interest of $148,867. The aggregate carrying value of $350,367 settled was credited to stockholders’ equity, consisting of common stock at par value of $300 and additional paid-in capital of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--GreentreePromissoryNoteMember__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zroyyZZe7EX4" title="Conversion of convertible securities value">350,067, resulting in the complete settlement of the related debt with no gain or loss recognized on conversion.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">● </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On March 24, 2026, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260324__20260324__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGCzlfTVCO3h" title="Stock issued for service">30,000 shares of common stock to settle previously recognized stock payable related to consulting services incurred during the year ended December 31, 2025, resulting in settlement of stock payable in the amount of $60,000. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 4, 2026, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20260504__20260504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEK8relU72Ff" title="Stock issued for service">100,000 shares of common stock to D. Boral Capital LLC pursuant to a settlement agreement dated April 30, 2026, in full and final settlement of a dispute arising from the Company’s November 2025 underwritten public offering. The shares had a fair value of $92,780 on the settlement agreement date recorded as stock-based compensation. See Note 8 – Commitments and Contingencies.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 8, 2026, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesOther_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zAzhsKrUW9B5" title="Number of shares issued">150,000 shares of common stock to its former Chief Financial Officer pursuant to a Settlement Agreement and General and Mutual Release dated May 1, 2026. The shares had a fair value of $<span id="xdx_90E_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20260508__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zgSGBB0gy985" title="Common stock payable">186,000 on the settlement agreement date recorded as stock-based compensation. See Note 8 – Commitments and Contingencies.</td></tr> </table> Repurchase of Shares from Related Party - During the six months ended June 30, 2026, the Company entered into multiple stock repurchase agreements with certain related party shareholders in connection with the Company’s Series A Convertible Preferred Stock private placement (the “PIPE” offering). Pursuant to these agreements, the Company repurchased and retired an aggregate of <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_z8GqazCDDczk" title="Aggregate repurchased shares">6,250,000 shares of common stock for total consideration of $3,075,000 in cash. These transactions included: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BrianSJohnMember_zZFBpZPRfPz5" title="Stock repurchase, shares">1,250,000 shares repurchased from Brian S. John for $<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodValue_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BrianSJohnMember_z00aIghjywf3" title="Stock repurchase">1,250,000 ($<span id="xdx_90B_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BrianSJohnMember_ziVUMdnfa6E2" title="Share price">1.00 per share)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TylerMooreMember_zKJXHrmPWCc9" title="Stock repurchase, shares">1,500,000 shares repurchased from Tyler Moore for $<span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodValue_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TylerMooreMember_zrea7uf1Vk09" title="Stock repurchase">750,000 ($<span id="xdx_907_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TylerMooreMember_zfKHI5laiic6" title="Share price">0.50 per share)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--NovoDXMember_z3d3hdyTZAGe" title="Stock repurchase, shares">3,500,000 shares repurchased from NovoDX for $<span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodValue_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--NovoDXMember_zvhyxetrnPk9" title="Stock repurchase">1,075,000 ($0.307 per share)</td></tr> </table> All repurchased shares were retired upon acquisition and these transactions were approved by the disinterested members of the Company’s Board of Directors. The repurchase of <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BrianSJohnMember_zKb35GtJfxL8" title="Stock repurchase, shares">1,250,000 shares from Brian S. John was made at $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BrianSJohnMember_z8joJXpZj835" title="Share price">1.00 per share, which exceeded the estimated fair market value of the common stock of $0.89 per share on the repurchase date. The excess of the repurchase price over fair market value of $<span id="xdx_904_ecustom--ExcessOfRepurchasePriceOverFairMarketValue_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP4T2Jeyhp67" title="Excess of repurchase price over fair market value">137,500 was recognized as a stock-based compensation charge with a corresponding credit to additional paid-in capital. All remaining amounts were recorded as reductions to common stock and additional paid-in capital within the accompanying statements of stockholders’ equity. Each of the above transactions constitutes a related party transaction as defined under ASC-850. Receivable from Related Party for Stock Repurchase – As of June 30, 2026, the Company had advanced $<span id="xdx_902_ecustom--TemporaryEquityStockIssuedDuringPeriodValueAdvanceForRepurchaseOfCommonStock_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z1NRrGPJaVz4" title="Advance receivable from related party for stock repurchase">150,000 in respect of the repurchase and retirement of <span id="xdx_90F_ecustom--TemporaryEquityStockIssuedDuringPeriodSharesAdvanceForRepurchaseOfCommonStock_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z23WV2IQMz8h" title="Advance receivable from related party for stock repurchase, shares">150,000 shares of the Company’s common stock held by insiders, as required by the use-of-proceeds provisions of the Securities Purchase Agreement dated May 29, 2026. Because the Company’s obligation to apply these proceeds to reacquire a fixed number of its own shares was established by that agreement prior to June 30, 2026, the advance does not represent a recoverable asset and has been recorded as a reduction of stockholders’ equity, as of June 30, 2026. The <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXnbN2XjkUH8" title="Number of shares issued">150,000 shares remained outstanding as of June 30, 2026 and had not been cancelled. See Note 13 – Subsequent Events. Preferred Stock – The Company has 1,000,000 shares of preferred stock, par value $0.001 authorized. There were no shares issued and outstanding as of June 30, 2026 and December 31, 2025. Series A Convertible Preferred Stock - Mezzanine Equity On March 19, 2026, the Company designated <span id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zM4zeCSVlQyc" title="Temporary equity, shares authorized">4,000 shares of its preferred stock as Series A Convertible Preferred Stock, with a stated value of $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zcUgqBcY3xbl" title="Temporary equity, par value">1,000 per share. On July 10, 2026, the Company filed an amendment to the Certificate of Designation, increasing the number of designated Series A shares from 4,000 to 4,500. See Note 13 – Subsequent Events. On March 19, 2026, the Company entered into a Securities Purchase Agreement in connection with a private investment in public equity (the “PIPE Offering”), pursuant to which the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260319__20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi1sRrN5jx71" title="Shares issued">3,789.474 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) with a stated value of $<span id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9HxANi1qqP7" title="Shares issued, stated value">1,000 per share, for an aggregate stated value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260319__20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuoIBbrir0Hh" title="Shares issued, value">3,789,474, together with warrants to purchase 9,473,685 shares of common stock at an exercise price of $0.40 per share. The purchase price was $<span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zN3gQkpdCxl3" title="Share price">950 per share, resulting in gross proceeds of approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_pn5n6_c20260319__20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zprhtXCYsQU9" title="Gross proceeds">3.5 million after giving effect to a <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzUJvxnHdOsf" title="Original issue discount">5% original issue discount. The Series A Preferred Stock is convertible into shares of the Company’s common stock at a conversion price of $<span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20260319__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBMzADoc5g13" title="Conversion price">0.40 per share, subject to certain limitations and adjustments, including beneficial ownership limitations and shareholder approval requirements. The Series A Preferred Stock ranks senior to the Company’s common stock with respect to liquidation. In addition, the Series A Preferred Stock includes redemption provisions that allow the holder to require cash redemption upon the occurrence of specified triggering events. The Series A Preferred Stock is redeemable at the option of the holder upon the occurrence of a Triggering Event, defined as (i) the objection or rejection by the Trading Market, any Governmental Entity, or any regulatory or self-regulatory agency of any of the transactions contemplated by the Securities Purchase Agreement on or before December 31, 2026, or (ii) the failure of any regulatory or self-regulatory agency to approve all such transactions, if any such approval is required, on or before December 31, 2026. Upon the occurrence and continuance of a Triggering Event, following a ten (10) day opportunity to cure, the holder may require the Company to redeem all or any portion of the Series A Preferred Stock at a redemption price equal to <span id="xdx_902_ecustom--RedemptionPricePercentage_iI_pid_dp_uPure_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjbrqyKe5xrb" title="Redemption price percentage">100% of the consideration paid, plus any accrued but unpaid dividends and all other costs and expenses, including legal fees, incurred in connection with the Triggering Event (the “Triggering Redemption Amount”). The Triggering Redemption Amount is due and payable within ten (10) Trading Days of the holder’s redemption notice. If the Company fails to pay the Triggering Redemption Amount when due, interest accrues at the lesser of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zli6mhoKe6le" title="Interest rate">10% per annum or the maximum rate permitted by applicable law until paid in full. As of June 30, 2026, the base Triggering Redemption Amount was approximately $<span id="xdx_90B_eus-gaap--PreferredStockRedemptionAmount_iI_pn5n6_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8cfeV2kGDAc" title="Redemption Amount">4.2 million, exclusive of accrued dividends, legal fees, and other applicable costs, which could increase the total redemption obligation. Due to the existence of redemption features that are not solely within the control of the Company, the Series A Preferred Stock is classified as mezzanine equity in accordance with ASC 480-10-S99 (SEC Staff guidance). On April 7, 2026, the Company received a Staff Delisting Determination letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on The Nasdaq Capital Market (the “Stockholders’ Equity Rule”), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. For the periods that management determined it was probable that the Preferred Shares would become redeemable, the Company had elected to carry the shares at the maximum redemption value, or fair value, in mezzanine equity on the consolidated balance sheets. For the reporting period through June 30, 2026, all Preferred Shares were recognized at their maximum redemption value. During the six months ended June 30, 2026 and 2025, the Company recognized $2,062,360 and nil, respectively, in accretion of the Preferred Shares to redemption value within mezzanine equity on the consolidated balance sheets. As of June 30, 2026, there were <span id="xdx_90C_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z5A1oPxUsSE2" title="Temporary equity, shares outstanding">4,233 shares of Series A Preferred Stock issued and outstanding, carried at an aggregate redemption value of $<span id="xdx_906_eus-gaap--RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlKrMVWGcCYk" title="Carrying value">4,232,686. On May 29, 2026, the Company entered into a second Securities Purchase Agreement under the PIPE Offering with an accredited investor, pursuant to which the Company agreed to issue <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260529__20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTbFnWKFHDT5" title="Number of shares issued">444 shares of Series A Preferred Stock with an aggregate stated value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueOther_c20260529__20260529__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGh7q0J1u35a" title="Value of shares issued">443,212, together with warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z3XAUVtjr5n1" title="Warrants purchase">1,052,632 shares of common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zSuyzXlTCiT2" title="Exercise price">0.40 per share, for an aggregate purchase price of $<span id="xdx_900_eus-gaap--PaymentsForRepurchaseOfOtherEquity_c20260529__20260529__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zFJUQuncRMvd" title="Purchase price">400,000 after giving effect to a <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zC5N2ljHPOmj" title="Original issue discount">5% original issue discount. The subscription proceeds of $400,000 were received in June 2026, and the final transaction documents were executed in July 2026 (see Note 13 – Subsequent Events). Consistent with the initial tranche, the proceeds were allocated between the Series A Preferred Stock and the warrants, and the preferred stock was accreted to its redemption value of $<span id="xdx_908_eus-gaap--PreferredStockRedemptionAmount_iI_c20260630__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zLC6nvxb90k" title="Redemption Amount">443,212 as of June 30, 2026. Holders of the Series A Preferred Stock are entitled to an 8% dividend payable in cash or shares of common stock at the holder’s option. In addition, holders shall be entitled to receive, and the Company shall pay, dividends on shares of Series A Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. As of June 30, 2026, the accrued dividend was $ 88,508. Common Stock Payable – The Company entered into consulting agreements under which it committed to issue shares of common stock for services rendered. As of June 30, 2026, the Company had recorded an aggregate of $258,780 in common stock payable, representing the fair value of shares committed but not yet issued under various consulting, employment settlement, and contractual settlement agreements, as further described below. The Company entered the following consulting agreements: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Under the first agreement, 30,000 shares were committed with a total fair value of $60,000. These shares were issued on March 24, 2026 as a settlement of stock payable in the amount of $60,000. Under the second agreement, 300,000 shares were committed with a total fair value of $258,780. As of June 30, 2026, all 300,000 shares were payable and the full fair value has been recognized as common stock payable. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td>●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On September 4, 2025, the Company entered into an employment agreement with Mr. Tyler Moore, who served as the Company’s Chief Financial Officer until his resignation on January 5, 2026. Following his resignation, disputes arose between the parties regarding Mr. Moore’s equity compensation entitlement under the employment agreement. On May 1, 2026, the Company entered into a settlement agreement with Tyler Moore. The settlement agreement resolves disputes regarding Tyler Moore’s equity compensation under the employment agreement. Pursuant to the settlement agreement, the Company agreed to issue to Tyler Moore <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_c20250904__20250904__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zDAKFyr7RIR1" title="Common stock as equity compensation, shares">150,000 shares of the Company’s common stock as equity compensation, and accordingly recognized $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20250904__20250904__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zFwk94uxU58i" title="Common stock as equity compensation">186,000 of stock-based compensation, recorded as common stock payable, representing the fair value of the shares on the settlement date. The <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zStlYOXK0kCf" title="Common stock as equity compensation, shares">150,000 settlement shares were issued on May 8, 2026, and the related common stock payable of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20260508__20260508__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_znDOKoGuK0t2" title="Common stock as equity compensation">186,000 was extinguished (see Note 8 – Commitments and Contingencies).</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On April 30, 2026, the Company entered into a Settlement Agreement and General and Mutual Release (the “Settlement Agreement”) with D. Boral Capital (“D. Boral”). The Settlement Agreement resolves disputes arising from the Company’s completion of a private placement of its Series A Preferred Stock on March 19, 2026, which violated certain lock-up restrictions under the Underwriting Agreement dated November 12, 2025, prohibiting the Company from offering any of its securities for sale prior to May 12, 2026. Pursuant to the Settlement Agreement, the Company agreed to issue to D. Boral 100,000 shares of the Company’s common stock and to pay $100,000 in cash, in full and final satisfaction of any payment, stock issuance, or other compensation that may be owed to D. Boral under the Underwriting Agreement or otherwise. In consideration of such issuance and payment, D. Boral irrevocably and unconditionally released, acquitted, and forever discharged the Company and its principals from any and all claims, demands, rights, and causes of action. Because the shares and cash represent compensation for a contractual breach that occurred on March 19, 2026, the Company determined that date to be the measurement date for the shares. The fair value of the 100,000 shares on March 19, 2026 was $92,780. The 100,000 shares were issued on May 4, 2026 and, together with the $100,000 cash payment made on May 6, 2026, the related common stock payable of $92,780 was extinguished upon settlement (see Note 8).</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On December 23, 2025, the Company entered into a Consulting Agreement (the “Consulting Agreement”) with Genesis One Holdings, LLC (“Genesis One” or the “Consultant”) for consulting services to be provided to the Company over a term of 90 days. As compensation for such services, the Consultant is entitled to receive <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20251223__20251223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zTWlL02KPFRl" title="Shares issued for services">100,000 shares of the Company’s common stock per month as a fully paid engagement fee, together with a cash fee of $100,000 per month. On December 29, 2025, the Company paid the first monthly cash instalment of $100,000 and recorded the related stock-based compensation and consulting expense. During the three months ended March 31, 2026, the Company recognized $200,000 in cash consulting fees, accrued in accounts payable, and $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zgOMTJpKUNyd" title="Common stock as equity compensation">235,777 in stock-based compensation representing the fair value of shares earned during the period. As of June 30, 2026, the shares had not yet been issued and the corresponding obligation has been recorded as common stock payable.</td></tr> </table> Warrants – In April 2024, the Company issued 2,110,000 warrants to purchase common stock at a price of $3.00 per share, expiring on April 15, 2029. The warrants are only settled in shares with no cash option and were issued as part of the private placement. During the year ended December 31, 2025, the Company issued an additional <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--FinancingArrangementMember_zyAwVxcT0XBf" title="Additional warrant shares">230,000 warrants in connection with financing arrangements, consisting of: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">200,000 warrants issued to Greentree Financial Group Inc. on August 6, 2025, with an exercise price of $4.00 per share and a term of five years. The warrants were valued at $155,154 with a relative fair value of $74,267 recorded as a discount on the convertible note and additional paid in capital; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">30,000 warrants issued to D. Boral Capital LLC on November 14, 2025, with an exercise price of $4.00 per share and a term of five years. The warrants were valued at $10,260 and netted with additional paid in capital as offering costs on the IPO.</td></tr> </table> In connection with the PIPE Offering on March 19, 2026, the Company issued an aggregate of 9,473,685 warrants to purchase shares of its common stock. The warrants have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and expire five years from the date of issuance. The relative fair value allocated to these warrants of $1,525,133 was recorded as additional paid-in capital. The warrants were issued as part of the private placement transaction and are subject to certain beneficial ownership limitations. On May 29, 2026, in connection with the second tranche of the PIPE Offering, the Company issued an additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260529__20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zitdWb3IbNxf" title="Shares issued">1,052,632 warrants to purchase shares of its common stock. The warrants have an exercise price of $<span id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20260529__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zLgzPdcTrzF8" title="Shares issued, stated value">0.40 per share, are exercisable immediately upon issuance, and expire five years from the date of issuance. The relative fair value allocated to these warrants of $174,541 was recorded within additional paid-in capital. As of June 30, 2026, the Company had a total of 12,866,317 warrants outstanding, with a weighted average exercise price of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20260101__20260630_zNK0xBdtqw32" title="Weighted average price">0.89 and an aggregate intrinsic value of $8,842,106 based on the closing price of the Company’s common stock on June 30, 2026. The fair value of the warrants using the Black-Scholes Model with the following variables: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Stock Price - $0.93 - $1.75</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exercise Price - $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z0kmjoeRtgB7" title="Exercise price">0.40 - $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zIkNsjT7p5Wb" title="Exercise price">4.00 </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Volatility – <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIwxT8VdgHg3" title="Volatility minimum">72.30% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsNTXeVgd7Hd" title="Volatility maximum">78.45%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Term –<span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziIrjh1C8ex1" title="Term">5 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Risk Free Rate of Return – <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zy5nDwtZuuL8" title="Risk free interest rate, minimum">3.55% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znHimIrlPiF8" title="Risk free interest rate, maximum">4.13%</td></tr> </table> Stock Options – During the year ended December 31, 2025, the Company granted an aggregate of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zz1mlUX9TtI7" title="Stock option granted">175,000 stock options to directors. The options have exercise prices ranging from $<span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20251230__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4x7bTocFLcl" title="Stock option exercise price">1.13 to $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zfywpSld3Igd" title="Stock option exercise price">1.24 per share, with a weighted-average exercise price of approximately $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzQM99grCjBa" title="Weighted average exercise price">1.19 per share, and a contractual term of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc_c20250101__20251231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrxN7AjYuHwc" title=" Contractual term">five years. The total grant-date fair value of the options issued during 2025 was approximately $103,348. The Company recognized stock-based compensation expense of $52,123 and $23,166 related to these grants during the six and three months ended June 30, 2026, respectively. All option-related compensation cost has been fully recognized, and there was no remaining unamortized compensation expense as of June 30, 2026. As of June 30, 2026, the Company had <span id="xdx_90D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--StockOptionMember_zJBuKLAWrWS2" title="Stock options outstanding and exercisable">175,000 stock options outstanding, with a weighted-average exercise price of approximately $<span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--StockOptionMember_zbxEy1aawq81" title="Weighted average exercise price">1.19 per share and a weighted-average remaining contractual life of approximately <span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--StockOptionMember_zdrgpE1LYdAe" title="Contractual term">4.4 years. All <span id="xdx_909_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OptionMember_zr8MYN7aQUZh" title="Stock options outstanding and exercisable">175,000 options outstanding were exercisable as of June 30, 2026, with a weighted-average exercise price of approximately $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20260630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OptionMember_zYxPI3yRus4j" title="Weighted average exercise price">1.19 per share. The options outstanding had no aggregate intrinsic value as of June 30, 2026. The fair value of the stock options using the Black-Scholes Model with the following variables. The expected term is calculated using a simplified method for plain vanilla options: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Stock Price - $1.13</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exercise Price - $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_z1DPPS3JIhjc" title="Exercise price">1.13 - $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zAWq23ThHq1j" title="Exercise price">1.243</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Volatility – <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXuofsPdZyKk" title="Volatility minimum">84.77% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmR6Wgi663Q1" title="Volatility maximum">86.71%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Expected Term – <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MinimumMember_zeax4G1y0kC3" title="Term, minimum">2.5 –<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember__srt--RangeAxis__srt--MaximumMember_zj1X9sksAFX" title="Term, maximum"> 2.75 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Risk Free Rate of Return – <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zTFMuLK6OiOf" title="Risk free interest rate, minimum">3.54% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20260101__20260630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIZvYuAhW9Eh" title="Risk free interest rate, maximum">3.55%</td></tr> </table> Restricted Stock Units – During the year ended December 31, 2025, the Company granted an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuCljOBfbkN3" title="Stock option granted">822,592 restricted stock units (“RSUs”) to employees and service providers. The RSUs were granted at a fair value of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20250101__20251231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhHBuylb1S2g" title="Weighted average exercise price">1.13 per share and vest over periods through December 2026. The total grant-date fair value of the RSUs issued during 2025 was approximately $929,529. The Company forfeited a total of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkfRRPeF5YZg" title="Number of shares forfeited">300,000 RSUs during the six months ended June 30, 2026 and recognized stock-based compensation expense of $<span id="xdx_904_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z58uMAjSg4ag" title="Stock based compensation expense">469,816 and $<span id="xdx_907_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20260401__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsceMGLTMoS4" title="Stock based compensation expense">181,801 related to these RSUs during the six and three months ended June 30, 2026, respectively. The remaining unrecognized compensation expense of approximately $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJRL3ig9UGId" title="Cost not yet recognized">23,290 will be recognized over the remaining vesting period. As of June 30, 2026, the Company had <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCgiBB8EhMZ6" title="Restricted stock unit">522,592 RSUs outstanding.

100000000

0.001

9091506

14761925

299581

2.00

200000

1500

148867

0.7487

200000

148867

350367

300

350067

30000

60000

100000

92780

150000

186000

6250000

3075000

1250000

1.00

1500000

750000

0.50

3500000

1075000

0.307

1250000

1.00

0.89

137500 150000 150000

150000

1000000

0.001

4000

1000

4000

4500

3789.474

1000

3789474

9473685

0.40

950

3500000

0.40

0.10

4200000

2500000

35000000

500000

2062360

4233

4232686

444

443212

1052632

0.40

400000

0.05

400000

443212

0.08

88508

258780

30000

60000

300000

258780

300000

150000

186000

150000

186000

100000

92780

100000

92780

100000

200000

235777

2110000

3.00

2029-04-15

230000

200000

4.00

P5Y

155154

74267

30000

4.00

P5Y

10260

9473685

0.40

1525133

1052632

0.40

174541

12866317

0.89

8842106

0.93

1.75

0.40

4.00

0.7230

0.7845

P5Y

0.0355

0.0413

175000

1.13

1.24

1.19

P5Y

103348

52123

23166

175000

1.19

P4Y4M24D

175000

1.19

1.13

1.243

0.8477

0.8671

P2Y6M

P2Y9M

0.0354

0.0355

822592

1.13

929529

300000

469816

181801

23290

522592

Note 11 – Segment Report Operating segments are defined as components of an enterprise for which separate financial information is available and regularly reviewed by the chief operating decision maker (“CODM”) in allocating resources and assessing performance. The Company has determined that its CODM is the Chief Executive Officer. In accordance with ASC 280, Segment Reporting, the CODM evaluates financial performance and allocates resources based on consolidated results of operations. The Company operates as a single reporting unit and does not manage its business by separate product lines, service lines, or geographic divisions for purposes of internal reporting. Accordingly, the Company has determined that it operates in <span id="xdx_902_eus-gaap--NumberOfReportableSegments_dc_uSegment_c20260101__20260630__us-gaap--StatementBusinessSegmentsAxis__custom--SingleReportableSegmentMember_zdG2roMqvO23" title="Number of reportable segment">one reportable segment. Substantially all of the Company’s operations and long-lived assets are located in the United States. Because the Company operates in one reportable segment, consolidated net revenues, operating loss, net loss, and total assets as presented in the condensed consolidated financial statements represent segment results. Schedule of Reportable Segment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20260101__20260630_z5Svjp7fnSN5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20250630_zt7gVWPFtVT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_zjX5ubWvgIsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross profit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,656</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ProfessionalFees_zBBgnsuxrxa2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">730,627</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,945</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PayrollExpense_zA1VH5jUbwS4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,514,886</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856,147</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--GeneralAndAdministrativeExpense_ztAzpmUVhIrf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Selling, general and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,723</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,490</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNet_zKAIUra7zyK7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">287,028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">427</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DepreciationAndAmortization_zG8Efay6v1ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_iN_di_ziXA2nm6vzil" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other income</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(62</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentNetLoss_iT_zqtCGirhjqyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,199,353</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--ReconciliationOfProfitOrLoss_zz0InWdwmomg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AdjustmentsAndReconcilingItems_zAakWBbKi6m1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_zmfc0Ep1tvR" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consolidated net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,199,353</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260401__20260630_zw7869e7jXob" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250401__20250630_zmkPoAvRbElc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_z8ClYNg8LUXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross profit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">865</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ProfessionalFees_zi3zqBKFBDua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,003</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PayrollExpense_zRBNLEtf2z88" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">414,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">489,114</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--GeneralAndAdministrativeExpense_z5McWPmwk4ni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Selling, general and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,331</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNet_zOaxeYLXUVTb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DepreciationAndAmortization_zP9Lx7m1OMI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherNonoperatingIncomeExpense_iN_di_zrXCInApH4w8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other (income) loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(50</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentNetLoss_iT_zt7W1xZMU0Ri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(638,726</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(660,583</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--ReconciliationOfProfitOrLoss_zXhfYAgihWNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AdjustmentsAndReconcilingItems_zFAeQWLXVEYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_z9dKJQLaeF2f" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consolidated net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(638,726</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(660,583</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

Because the Company operates in one reportable segment, consolidated net revenues, operating loss, net loss, and total assets as presented in the condensed consolidated financial statements represent segment results. Schedule of Reportable Segment <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20260101__20260630_z5Svjp7fnSN5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250101__20250630_zt7gVWPFtVT2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Six Months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_zjX5ubWvgIsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross profit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,656</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ProfessionalFees_zBBgnsuxrxa2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">730,627</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,945</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PayrollExpense_zA1VH5jUbwS4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,514,886</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856,147</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--GeneralAndAdministrativeExpense_ztAzpmUVhIrf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Selling, general and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114,723</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,490</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNet_zKAIUra7zyK7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">287,028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">427</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DepreciationAndAmortization_zG8Efay6v1ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_iN_di_ziXA2nm6vzil" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other income</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(62</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentNetLoss_iT_zqtCGirhjqyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,199,353</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--ReconciliationOfProfitOrLoss_zz0InWdwmomg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AdjustmentsAndReconcilingItems_zAakWBbKi6m1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_zmfc0Ep1tvR" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consolidated net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,647,202</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,199,353</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260401__20260630_zw7869e7jXob" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20250401__20250630_zmkPoAvRbElc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months ended June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_z8ClYNg8LUXb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross profit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">865</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ProfessionalFees_zi3zqBKFBDua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198,364</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,003</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PayrollExpense_zRBNLEtf2z88" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Payroll expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">414,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">489,114</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--GeneralAndAdministrativeExpense_z5McWPmwk4ni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Selling, general and administrative expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,187</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,331</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNet_zOaxeYLXUVTb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DepreciationAndAmortization_zP9Lx7m1OMI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherNonoperatingIncomeExpense_iN_di_zrXCInApH4w8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Other (income) loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(50</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--SegmentNetLoss_iT_zt7W1xZMU0Ri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(638,726</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(660,583</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--ReconciliationOfProfitOrLoss_zXhfYAgihWNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AdjustmentsAndReconcilingItems_zFAeQWLXVEYj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_z9dKJQLaeF2f" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consolidated net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(638,726</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(660,583</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

1656

730627

142945

1514886 856147

114723

51490

287028

427

150000

-2647202 -1199353

-2647202

-1199353

865

198364

75003

414186 489114

26187

21331

75000

-1000

-638726 -660583

-638726

-660583

Note 12 – Income Taxes We record tax positions as liabilities in accordance with ASC 740 and adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of certain tax uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the recognized tax benefit liabilities. These differences, if any, will be reflected as increases or decreases to income tax expense in the period in which new information becomes available. As of June 30, 2026 and December 31, 2025, the Company has not recorded any uncertain tax positions in the accompanying financial statements. The effective U.S. federal corporate income tax rate for the six months ended June 30, 2026 and the year ended December 31, 2025 was 21%. As of June 30, 2026, the Company had net operating loss carryforwards of approximately $8,614,368, compared to $7,141,162 as of December 31, 2025. These net operating losses may be carried forward indefinitely; however, their utilization may be subject to limitations under Section 382 of the Internal Revenue Code due to ownership changes and stock issuances. The significant components of the Company’s deferred tax assets were as follows: Schedule of Deferred Tax Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260630_zHB1k7DBQw5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231_znWJpJepT40f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iI_maDTANzkJ3_zf0HSpR1tfgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Deferred Tax Asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,809,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,499,644</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzkJ3_ziOAOorM6Eoe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation Allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,809,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,499,644</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzkJ3_zkUgHf391Qc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Deferred Tax Asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of June 30, 2026, the Company recorded a deferred tax asset of $1,809,017 primarily related to federal net operating loss carryforwards. Due to the Company’s cumulative losses and the lack of sufficient positive evidence to support realization, management determined that it is more likely than not that the deferred tax asset will not be realized. Accordingly, a full valuation allowance of $1,809,017 has been recorded as of June 30, 2026. As of December 31, 2025, the Company recorded a full valuation allowance of $1,499,644 against its deferred tax assets. The Company recorded no provision for income taxes for the six months ended June 30, 2026 and 2025 due to operating losses and the establishment of a full valuation allowance against its deferred tax assets.

0.21

8614368

7141162

The significant components of the Company’s deferred tax assets were as follows: Schedule of Deferred Tax Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20260630_zHB1k7DBQw5b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231_znWJpJepT40f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iI_maDTANzkJ3_zf0HSpR1tfgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Deferred Tax Asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,809,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,499,644</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzkJ3_ziOAOorM6Eoe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation Allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,809,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,499,644</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzkJ3_zkUgHf391Qc6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net Deferred Tax Asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1809017

1499644

1809017

1499644

1809017

1499644

Note 13 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed consolidated financial statements were available to be issued. As a result of this evaluation, the following material subsequent events were identified that required disclosure in the unaudited condensed consolidated financial statements: Special Meeting of Stockholders On July 9, 2026, the Company held a Special Meeting of Stockholders at which stockholders approved (i) the Additional Investment Right under the PIPE Offering, (ii) the issuance of shares of common stock upon conversion of the Series A Preferred Stock and exercise of the related warrants in excess of 19.99% of the shares outstanding prior to the PIPE Offering, and (iii) an increase in the number of authorized shares of common stock from 100,000,000 to 500,000,000. Amendment to Certificate of Designation and Completion of Second PIPE Tranche On July 10, 2026, the Company filed an amendment to the Certificate of Designation for the Series A Preferred Stock with the Secretary of State of the State of Nevada, increasing the number of designated Series A shares from 4,000 to 4,500. Also on July 10, 2026, the Company and the investor executed the final transaction documents for the second tranche of the PIPE Offering described in Note 10, covering the <span id="xdx_90A_ecustom--TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_pid_c20260710__20260710__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zU62zq4z6N9f" title="Proceeds allocated to Series A Preferred Stock, shares">444 shares of Series A Preferred Stock and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260710__20260710__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTGNC5wGg5ul" title="Shares issued">1,052,632 warrants for which subscription proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_c20260710__20260710__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3VPiAkLwrz1" title="Gross proceeds">400,000 were received in June 2026. Share Redemption Agreement with Related Party As contemplated by the use-of-proceeds provisions of the Securities Purchase Agreement governing the PIPE Offering described in Note 10, the Company was required to apply approximately $<span id="xdx_90B_ecustom--TemporaryEquityStockIssuedDuringPeriodValueAdvanceForRepurchaseOfCommonStock_c20260710__20260710__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqGlbW0qPwh6" title="Advance receivable from related party for stock repurchase">150,000 of the proceeds to retire <span id="xdx_90A_ecustom--TemporaryEquityStockIssuedDuringPeriodSharesAdvanceForRepurchaseOfCommonStock_pid_c20260710__20260710__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2OWPClNdeka" title="Advance receivable from related party for stock repurchase, shares">150,000 shares of common stock held by insiders. The Company advanced the $<span id="xdx_906_ecustom--TemporaryEquityStockIssuedDuringPeriodValueAdvanceForRepurchaseOfCommonStock_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc1yjv5ikA44" title="Advance receivable from related party for stock repurchase">150,000 prior to June 30, 2026, and the amount has been recorded as a reduction of stockholders’ equity as of June 30, 2026 (see Note 10). On July 10, 2026, the Company entered into a share redemption agreement with BK Investments, an entity affiliated with Mr. Brian John, the Company’s Interim Chief Financial Officer, providing for the repurchase and retirement of the <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260710__20260710__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__dei--LegalEntityAxis__custom--BKInvestmentsLLCMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zpQVfApKQfP1" title="Share issued">150,000 shares for aggregate consideration of $<span id="xdx_907_eus-gaap--Cash_iI_c20260710__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__dei--LegalEntityAxis__custom--BKInvestmentsLLCMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zV37xGVpMZX" title="Purchase price">150,000. On July 16, 2026, the repurchase was completed and the 150,000 shares were cancelled and retired. The par value of the cancelled shares was reclassified within stockholders’ equity. No further charge to stockholders’ equity was recognized upon closing, as the consideration had been recorded in the period the advance was made. Issuance of Shares Upon Vesting of Restricted Stock Units On July 13, 2026, the Company issued an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260713__20260713__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znapyOQS3LK9">476,720 shares of common stock upon the vesting and settlement of previously granted restricted stock units including, <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260713__20260713__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQw2oGHQ6kyf">126,720 shares issued to Dr. Glynn Wilson, the Company’s Chief Executive Officer. Conversion of Series A Preferred Stock Subsequent to June 30, 2026, the holder of the Company’s Series A Preferred Stock converted portions of its Series A Preferred Stock into shares of the Company’s common stock in accordance with the terms of the Series A Preferred Stock described in Note 10. In connection with such conversions, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260716__20260716__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF8Drfi3W4Ed" title="Stock issued during period, shares, conversion">300,000 shares of common stock on July 16, 2026, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260728__20260728__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhiXH9Vrzm6b" title="Stock issued during period, shares, conversion">450,000 shares on July 28, 2026, <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260731__20260731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMHIqdoojU72" title="Stock issued during period, shares, conversion">150,000 shares on July 31, 2026, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260806__20260806__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKQwTBcfgYr6" title="Stock issued during period, shares, conversion">50,000 shares on August 6, 2026, for an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260701__20260701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zl35e7knAeMk" title="Stock issued during period, shares, conversion">950,000 shares of common stock. Nasdaq Listing Update On July 17, 2026, the Company received a delisting determination from the Nasdaq Listing Qualifications Department relating to the previously disclosed stockholders’ equity deficiency. The Company requested a hearing before a Nasdaq Hearings Panel, which stayed any suspension or delisting action pending the hearing, which hearing is scheduled for August 25, 2026. There can be no assurance that the Company will regain compliance with the applicable listing requirements.

19.99

100000000

500000000

4000

4500

444

1052632

400000

150000 150000 150000

150000

476720

126720

300000

450000

150000

50000

950000

false false false false Due to the anti-dilutive effect, the computation of basic and diluted EPS did not include the shares underlying the exercise of warrants, options, RSUs and Series A preferred stock as the Company had a net loss for the three and six months ended June 30, 2026 and 2025.